Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 14, 2021 /PRNewswire/ -- Menarini Silicon Biosystems (MSB), a pioneer of liquid biopsy and single cell technologies today announced that Dana-Farber Cancer Institute and the Multiple Myeloma Research Foundation presented data in an oral presentation at the 2021 ASH Annual Meeting that showcases the importance of Non-Invasive Liquid Biopsy to Quantify and Molecularly Characterize Circulating Multiple Myeloma Cells (CMMC).
- Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCHCMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating Multiple Myeloma Cells
The study analysed185blood samples fromprecursor patients (75MGUS and110SMM) from the Dana-Farber Cancer Institute observational PCROWD study. - The oral presentation took place at the ASH 2021 Annual Meeting in Atlanta on Saturday December 11th at 10:45am.
- "As a patient focused organization, the MMRF is committed to advancing innovative research to improve clinical care and disease management.
- The Menarini Silicon Biosystems (MSB) Lab Services represent a global, comprehensive and integrated laboratory service involving state-of-the-art technologies.